FABHALTA
iptacopan
Listed by Novartis Pharmaceuticals Corporation
- Strength
- 200 mg/1
- Form
- Capsule
- Route
- Oral
- Class
- Complement Factor B Inhibitor
What it contains
- Iptacopan Hydrochloride 200 mg/1
FDA record
| Dosage form | Capsule |
|---|---|
| Route | Oral |
| Drug class | Complement Factor B Inhibitor |
| Approval route | NDA — original brand approval |
| NDC code | 0078-1189 |
| FDA application | NDA218276 |
| RxNorm concept | 2671074 |
| Package sizes listed | 1 |
| Marketed since | December 2023 |
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.